Skip to main content
DiaSorin

DiaSorin

  • Company
  • Research & Development
  • Immunodiagnostic Solutions
  • Molecular Solutions
  • People Culture
  • Investor Relations
546afe790818c7b83afe4035_ico-immuno.png

Immunodiagnostic Solutions

more
close

Immunodiagnostic Solutions

Clinical Areas

  • Infectious Diseases
  • Bone and Mineral
  • Endocrinology
  • Hypertension
  • Oncology
  • Stool Diagnostics
  • Autoimmunity
  • Cardiac and Brain Damages

Systems

  • CLIA
  • ELISA

Committed to efficiency

  • DiaLink 3000
  • DiaBox
  • LIAISON® XLine

The broadest Infectious Disease menu

Molecular Solutions

close

Molecular Solutions

  • Systems
  • Infectious Diseases
  • Onco-hematology
  • Events

  • Focus Diagnostics

Worldwide
contacts

more
close

Worldwide contacts

  • Industrial Sites
  • Branches
  • Immunodiagnostics distributors
  • Molecular diagnostics distributors

At the booth

more

At the booth

  • Upcoming events
  • Financial
  • Marketing
  • Past events

News

DiaSorin Scientific contribution at Euromedlab Athens
DiaSorin launches the new LIAISON® XL Zika Capture IgM
DiaSorin launches a new serology assay to be used with LIAISON® Analyzer Family: the LIAISON® H. pylori IgG
DiaSorin scientific contribution at ECCMID Amsterdam 2016
DiaSorin makes Bordetella Pertussis and Brahms PCT II Gen tests available in Chemiluminescence
DiaSorin scientific contribution at IFCC WorldLab
DiaSorin launches the test for Calprotectin
FDA approves 1,25 Vitamin D in the US market

DiaSorin, the Diagnostic Specialist

Educational

more
close

Educational

  • Clinical areas
  • Educational videos
  • Articles & posters
  • U.S. Webinars
  • DiaSorin Symposia
Catalog
Dialog
  • Download DiaSorin app
    for laboratories

Search form

  • English
  • Italiano

DiaSorin S.p.A. - Share Capital € 55.948.257 R.E.A. 180729
Fiscal Code and Subscription to Vercelli Companies Register no 13144290155

  • Legal Notices
  • Privacy Policy
  • Modern Slavery Act Statement
Scroll down
▼
close
Android Iphone